FRANCHON CARTER: Open Payments
NPI 1295823623 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 55 payments from 11 companies in 2025. Trend: 2023 $1,532 · 2024 $1,189 · 2025 $1,306
Food & beverage: $1,207Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $245 |
| Neurocrine BioSciences, Inc. | 9 | $236 |
| Vanda Pharmaceuticals Inc. | 8 | $233 |
| E.R. Squibb & Sons, L.L.C. | 9 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Lundbeck LLC | 2 | $58 |
| Alkermes, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
Products named: INGREZZA, FANAPT, COBENFY, ABILIFY MAINTENA, CAPLYTA, UZEDY, AUSTEDO XR, ARISTADA.
Industry payments across GA — which companies pay providers there.
